First patients test novel Cancer-Fighting antibody in hope for tough tumors
Disease control
Ongoing
This is the first study in people testing a new drug called DM919, which is designed to help the immune system fight cancer. Researchers want to find safe and effective doses when DM919 is given alone or combined with another cancer drug (pembrolizumab) to 160 adults with advance…
Phase: PHASE1 • Sponsor: D2M Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC